Nutritional composition capable of improving the bioavailability of aromatic amino acids and its application

By controlling the ratio of protein, taurine and choline in infant formula foods, the bioavailability of aromatic amino acids is improved, and the problem of low amino acid utilization in existing infant formula foods is solved, and a higher level of Protein quality and healthy growth of infants and young children.

CN118415243BActive Publication Date: 2024-11-05INNER MONGOLIA YILI IND GROUP CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410900433.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-05
Publication Date
2024-11-05
Estimated Expiration
2044-07-05

AI Technical Summary

Technical Problem

The amino acid composition of cow milk protein in existing formula foods is very different from that of wet nurses, resulting in relatively low protein quality and low bioavailability of amino acids. How to meet the demand for amino acids in infants while reducing protein concentration is a challenge.

Method used

By controlling the mass ratio of protein, taurine and choline in infant formula foods, ensure that it is within the range of 1:0.0019-0.01:0.008-0.02, combining plant or animal protein, preferably using bovine or goat milk protein, adding Taurine and choline are used to increase the bioavailability of aromatic amino acids.

Benefits of technology

Effectively improve the digestibility and absorption utilization rate of tyrosine, phenylalanine and tryptophan, improve the digestion and absorption of protein by infants and young children, meet the demand for amino acids in infants and young children, and avoid excessive amino acids on immature kidneys. and the burden of the liver.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118415243B_ABST
    Figure CN118415243B_ABST
Patent Text Reader

Abstract

The present invention provides a nutritional composition capable of improving the bioavailability of aromatic amino acids and its application. The present invention first provides a composition comprising: protein, taurine and choline, wherein the mass ratio of protein, taurine and choline is 1: (0.0019-0.01): (0.008-0.02). The present invention also provides a food comprising the composition, and the application of the composition or food in the preparation of a product for improving the bioavailability of aromatic amino acids.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of nutritional compositions, and in particular relates to a nutritional composition capable of improving the bioavailability of aromatic amino acids and related applications. Background Art

[0002] Aromatic amino acids refer to amino acids with a benzene ring structure in their molecular structure, mainly including tyrosine, phenylalanine and tryptophan. Aromatic amino acids play an important role in life activities. A study on small for gestational age (SGA) infants analyzed the relationship between the content of aromatic amino acids in the blood of full-term infants and full-term SGA infants and their growth and development. The results showed that appropriate supplementation of aromatic amino acids in the diet of full-term SGA infants is beneficial to the growth and development of full-term SGA infants.

[0003] Tyrosine is a semi-essential amino acid required for the growth and development of infants and young children. Tyrosine can be synthesized in the body, but it can only be produced from the hydroxylation of phenylalanine. Tyrosine and phenylalanine are used together to synthesize important neurotransmitters and hormones, and participate in the body's sugar metabolism and fat metabolism. Tyrosine is an important raw material for the formation of a variety of hormones and functional substances such as adrenaline, norepinephrine, thyroxine, and melanin. Among them, thyroid hormone is one of the important factors in maintaining the normal metabolism of blood lipids and affecting protein synthesis. Changes in thyroid function are closely related to the metabolism of other substances in the body (such as glucose, protein, fat, and water and electrolyte balance).

[0004] Phenylalanine is an essential amino acid for the growth and development of infants and young children. It participates in protein synthesis and is closely related to the metabolism and health of infants and young children. Phenylalanine can be converted into tyrosine through metabolism. Phenylalanine hydroxylation is an important step to eliminate excess phenylalanine in the body and provide tyrosine. However, compared with adults, infants and young children have lower phenylalanine-4-monooxygenase activity and limited phenylalanine metabolic conversion capacity. Therefore, providing an appropriate amount of phenylalanine is crucial for the growth and development of infants and young children.

[0005] Tryptophan is another important aromatic amino acid. It is not only an essential amino acid for protein synthesis, but also an important pathway for serotonin metabolism and kynurenic acid metabolism. The metabolites of the serotonin pathway are serotonin and melatonin, both of which are involved in almost all physiological activities, including appetite regulation, digestion, circadian rhythm, cognition, learning and memory. Tryptophan can produce kynurenine, niacin and nicotinamide adenine dinucleotide (NAD) through the kynurenic acid metabolic pathway. Research data show that tryptophan in the diet can regulate infant sleep patterns and also affect brain development in early life, especially neuronal circuits and neuronal plasticity.

[0006] Providing infants with sufficient quantities and types of amino acids is crucial for their growth, because the rate of protein synthesis in the body is limited by the limiting essential amino acids in the diet. Previous studies have shown that the first limiting amino acid in infant formula is tryptophan, and the second and third limiting amino acids are phenylalanine and tyrosine. On the other hand, excessive amino acid intake is also a burden on the immature kidneys and livers of infants. How to meet the needs of infants for amino acids while reducing protein concentration has always been a challenge for infant formula.

[0007] The amino acid composition of cow's milk protein is quite different from that of breast milk, which makes the protein quality of infant formula foods with cow's milk as the main protein source relatively low, and the bioavailability of amino acids is low. Therefore, it is necessary to make targeted adjustments and optimizations when developing infant formula foods to improve protein quality, improve the bioavailability of amino acids, and promote amino acids to be more conducive to infant absorption. Summary of the invention

[0008] An object of the present invention is to provide a composition that can improve the bioavailability of aromatic amino acids.

[0009] Another object of the present invention is to provide a product, such as a food, comprising the composition.

[0010] Another object of the present invention is to provide related applications of the composition or food in improving the bioavailability of aromatic amino acids.

[0011] In one aspect, the present invention provides a composition comprising: protein, taurine and choline, wherein the mass ratio of protein, taurine and choline is 1: (0.0019-0.01): (0.008-0.02).

[0012] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0020-0.01): (0.0085-0.02).

[0013] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0021-0.009): (0.0085-0.019).

[0014] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0022-0.009): (0.0085-0.018).

[0015] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0023-0.009): (0.0085-0.017).

[0016] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0024-0.0085): (0.0085-0.016).

[0017] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0025-0.0085): (0.010-0.015).

[0018] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0019-0.008): (0.008-0.02).

[0019] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0020-0.008): (0.009-0.02).

[0020] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0021-0.007): (0.0090-0.020).

[0021] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0022-0.006): (0.010-0.019).

[0022] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0023-0.0055): (0.010-0.018).

[0023] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0024-0.0050): (0.010-0.015).

[0024] According to some specific embodiments of the present invention, in the composition of the present invention, the mass ratio of protein, taurine and choline is 1: (0.0025-0.0035): (0.010-0.015).

[0025] According to a specific embodiment of the present invention, in the composition of the present invention, the protein may be a vegetable protein and / or an animal protein. In some specific embodiments of the present invention, the protein comprises a milk protein, preferably selected from cow's milk protein and / or goat's milk protein. In some specific embodiments of the present invention, the protein may be, for example, a protein derived from cow's milk, including cow's milk total protein, specifically commercially available milk protein powder or whey protein powder. In some specific embodiments of the present invention, the whey protein content of the protein is not less than 40%, preferably not less than 60%.

[0026] According to a specific embodiment of the present invention, in the composition of the present invention, the choline and taurine can be obtained from conventional commercial sources.

[0027] According to a specific embodiment of the present invention, the composition of the present invention is a nutritional composition or a food composition.

[0028] In some specific embodiments of the present invention, the composition of the present invention may be mainly composed of protein, choline and taurine.

[0029] In other specific embodiments of the present invention, the composition of the present invention, especially the nutritional composition or food composition, in addition to the protein, taurine and choline, may also include other components, such as one or more of other proteins, fats, carbohydrates, vitamins, minerals, etc.

[0030] On the other hand, the present invention also provides the use of the composition in preparing a product for improving the bioavailability of aromatic amino acids.

[0031] In some specific embodiments of the present invention, the product is a nutritional product.

[0032] In some specific embodiments of the present invention, the product is a food.

[0033] In some specific embodiments of the present invention, the product is a nutritional supplement, a baby food supplement, an infant formula, a toddler formula, or an infant formula for special medical purposes.

[0034] In another aspect, the present invention further provides a food comprising the composition of the present invention.

[0035] According to some specific embodiments of the present invention, in the food of the present invention, the added amount of the composition of the present invention (i.e. the aforementioned composition comprising protein, taurine and choline) in the food can be 6g-36g / 100g of food dry matter based on the protein therein.

[0036] According to some specific embodiments of the present invention, the total protein content in the food of the present invention may be 6 g-36 g / 100 g of food dry matter.

[0037] According to a specific embodiment of the present invention, in the food of the present invention, the taurine content is 20 mg-86 mg / 100 g of food dry matter.

[0038] According to some specific embodiments of the present invention, in the food of the present invention, the taurine content is 20 mg-65 mg / 100 g of food dry matter.

[0039] According to some specific embodiments of the present invention, in the food of the present invention, the taurine content is 25 mg-55 mg / 100 g of food dry matter.

[0040] According to some specific embodiments of the present invention, in the food of the present invention, the taurine content is 25 mg-45 mg / 100 g of food dry matter.

[0041] According to some specific embodiments of the present invention, in the food of the present invention, the taurine content is 25 mg-40 mg / 100 g of food dry matter.

[0042] According to a specific embodiment of the present invention, in the food of the present invention, the content of choline is: 90mg-200mg / 100g food dry matter.

[0043] According to some specific embodiments of the present invention, in the food of the present invention, the content of choline is 100 mg-200 mg / 100 g of food dry matter.

[0044] According to some specific embodiments of the present invention, in the food of the present invention, the content of choline is 110 mg-200 mg / 100 g of food dry matter.

[0045] According to some specific embodiments of the present invention, in the food of the present invention, the content of choline is 110 mg-190 mg / 100 g of food dry matter.

[0046] According to some specific embodiments of the present invention, in the food of the present invention, the content of choline is 120 mg-150 mg / 100 g of food dry matter.

[0047] In some specific embodiments of the present invention, the food is milk powder or liquid milk.

[0048] In some specific embodiments of the present invention, the food is infant formula, toddler formula or infant formula for special medical purposes.

[0049] In some specific embodiments of the present invention, the food of the present invention is milk powder, which can be prepared by adding / adjusting protein, taurine and choline in a basic formula powder. Wherein, after the milk powder of the present invention is prepared, the content of protein, taurine and choline can be determined using conventional methods in the field, such as high performance liquid chromatography detection and analysis technology. There is no particular restriction on the basic formula powder in the present invention, as long as it is a milk powder formula commonly used in the art. For example, the basic formula powder can be an ordinary infant formula powder or a toddler formula powder. As a specific example, the basic formula powder of the present invention can be based on milk powder of animal origin as the main raw material, and can be further added with one or more of whey powder, vitamins, minerals, etc. As milk powder of animal origin, cow milk powder or goat milk powder can be used.

[0050] In the food of the present invention, the amount of each substance should meet the requirements of relevant standards.

[0051] On the other hand, the present invention also provides the use of the food in preparing a product for improving the bioavailability of aromatic amino acids.

[0052] According to a specific embodiment of the present invention, in the present invention, the aromatic amino acid includes one or more of tyrosine, phenylalanine and tryptophan; preferably includes one or more of tyrosine and tryptophan.

[0053] According to a specific embodiment of the present invention, in the present invention, the improvement of aromatic amino acid bioavailability includes improving the digestibility and / or absorption utilization of one or more of tyrosine, phenylalanine and tryptophan. Preferably, the improvement of aromatic amino acid bioavailability includes improving the digestibility and / or absorption utilization of one or more of tyrosine and tryptophan.

[0054] On the other hand, the present invention also provides a method for improving the bioavailability of aromatic amino acids in protein-containing foods, the method comprising: controlling the content of protein, taurine and choline in the food so that the mass ratio of protein, taurine and choline is 1: (0.0019-0.01): (0.008-0.02). Preferably, the mass ratio of protein, taurine and choline is controlled within the more specific range of the aforementioned present invention, that is, the mass ratio of protein, taurine and choline is preferably controlled to be 1: (0.0020-0.01): (0.0085-0.02), 1: (0.0021-0.009): (0.0085-0.019), 1: (0.0022-0.009): (0.0085-0.018), 1: (0.0023-0.009): (0.0085-0.017), 1: (0.0024-0.0085): (0.0085-0.016), 1: (0.0025-0.0085): (0.01 0-0.015), 1: (0.0019-0.008): (0.008-0.02), 1: (0.0020-0.008): (0.009-0.02), 1: (0.0021-0.007): (0.0090-0.020), 1: (0.0022-0.006): (0.010-0.019), 1: (0.0023-0.0055): (0.010-0.018), 1: (0.0024-0.0050): (0.010-0.015) or 1: (0.0025-0.0035): (0.010-0.015).

[0055] In some specific embodiments of the present invention, the present invention investigates the effect of the composition of the present invention on the bioavailability of aromatic amino acids in a piglet model experiment. First, the weight changes of piglets were tracked to confirm that the test formula had no effect on the growth and development of piglets. Subsequently, the amino acid composition of the test groups was determined, and there was basically no significant difference in the aromatic amino acids of the four test formulas. Subsequently, a 15-day feeding experiment was carried out, and after the end, the terminal ileum chyme samples were collected to avoid the influence of intestinal microorganisms on the determination. After analyzing the amino acid composition in the chyme samples, the apparent and standard digestibility were calculated, confirming that the composition of the present invention can improve the digestion and absorption rate of aromatic amino acids, especially tryptophan and tyrosine.

[0056] The composition of the present invention comprising protein, taurine and choline can improve the digestion and absorption of protein by infants and young children, especially can increase the digestibility and / or absorption utilization rate of aromatic amino acids, which is beneficial to the healthy growth of infants and young children. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1The figure shows the changes in body weight of experimental animals in different groups in the specific embodiments of the present invention.

[0058] Figure 2 The results show the composition of acidic aromatic amino acids determined in different groups of experimental animals in the specific embodiments of the present invention.

[0059] Figure 3 The apparent digestibility of protein in different groups of experimental animals in the specific embodiments of the present invention is shown.

[0060] Figure 4 The figure shows the apparent digestibility of aromatic amino acids measured in different groups of experimental animals in the specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates a significant difference between the groups.

[0061] Figure 5 The figure shows the apparent digestibility of aromatic amino acids (combined) measured in different groups of experimental animals in a specific embodiment of the present invention. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates a significant difference between the groups.

[0062] Figure 6 The standard digestibility of aromatic amino acids measured in different groups of experimental animals in the specific embodiment of the present invention is shown. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups.

[0063] Figure 7 The standard digestibility of aromatic amino acids (combined) measured by different groups of experimental animals in a specific embodiment of the present invention is shown. In the figure, two groups marked with the same letter indicate no statistical difference between the groups, and if the marked letters do not have the same letter, it indicates that there is a significant difference between the groups. DETAILED DESCRIPTION

[0064] Before further describing the specific embodiments of the present invention, it should be understood that the scope of protection of the present invention is not limited to the specific embodiments described below; it should also be understood that the terms used in the examples of the present invention are for describing the specific embodiments rather than for limiting the scope of protection of the present invention.

[0065] When the embodiments give numerical ranges, it should be understood that, unless otherwise specified in the present invention, both endpoints of each numerical range and any numerical value between the two endpoints can be selected. Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those generally understood by those skilled in the art. In addition to the specific methods, equipment, and materials used in the embodiments, according to the grasp of the prior art by those skilled in the art and the record of the present invention, any methods, equipment, and materials of the prior art similar or equivalent to the methods, equipment, and materials described in the embodiments of the present invention can also be used to realize the present invention.

[0066] Unless otherwise stated, the experimental methods, detection methods, and preparation methods disclosed in the present invention all adopt conventional techniques in the technical field.

[0067] In the embodiment, the protein used is derived from cow's milk whey protein powder, wherein the whey protein content is ≥60%.

[0068] In the examples, the taurine and choline used were commercially available.

[0069] Efficacy experiment of nutritional composition in improving bioavailability of aromatic amino acids

[0070] The experiment selected 7-day-old piglets with an initial weight of 2.8-3.1kg. Based on the principle of similar average weight, the piglets were randomly divided into 4 groups, with 6 piglets in each group. Each group was fed with a formula for 15 days, at a feeding rate of 42g dry matter / kg body weight, and the piglets' food intake, weight gain, and adverse reactions such as diarrhea were observed. The piglets were killed on the 15th day of the experiment, and the chyme samples of the terminal ileum of the piglets were collected.

[0071] The piglets are housed individually in special feeding boxes with a temperature controlled at 26-28°C, a relative humidity controlled at 40-70%, artificial lighting, and a 12-hour light-dark cycle.

[0072] In addition to the 4 test groups, a nitrogen-free diet group was set up, consisting of 5 7-day-old piglets with an initial body weight of 2.8-3.0Kg. The nitrogen-free diet group (the main components were carbohydrates and minerals, and there was no protein component) was set up to determine the basic endogenous loss of protein and amino acids, so as to calculate the standard digestibility of each amino acid in different groups later.

[0073] The food fed to each group was prepared with reference to the basic powder of infant formula and the protein, taurine and choline contents were adjusted. The specific composition of the formula is shown in Table 1.

[0074] Table 1

[0075]

[0076] Note: Vitamins and minerals are added in accordance with regulatory requirements and the content in each group of food is consistent.

[0077] Aromatic amino acid detection:

[0078] Phenylalanine and tyrosine were tested after hydrolysis with 6 mol / L hydrochloric acid solution for 22 hours according to the method in GB / T 5009.124-2016 "Determination of Amino Acids in Food". Tryptophan was tested after the sample was hydrolyzed with potassium hydroxide according to GB / T15400-2018 and chromatography. The three aromatic amino acids in each group and the collected chyme samples were tested, and the apparent digestibility and ileal standard digestibility of amino acids in different groups were calculated respectively.

[0079] Data processing and statistical analysis:

[0080] Apparent digestibility of protein in the fed diet (%) = [(total protein intake - ileal chyme protein) / total protein intake] × 100;

[0081] Apparent digestibility of amino acids in the diet (%) = [(amount of amino acids ingested - amount of the same amino acids in ileal chyme) / amount of amino acids ingested] × 100;

[0082] The standard digestibility of amino acids in the fed food (%) = [(amount of ingested amino acids - amount of the same amino acids in the ileal chyme + amount of the same amino acids endogenous in the ileum) / amount of ingested amino acids] × 100.

[0083] It can be seen that the protein digestibility measured in the present invention refers to the ratio of the protein in the food that can be absorbed and utilized by the digestive tract of the organism after digestion (including peptides and amino acids produced after digestion) to the total amount of protein ingested; the amino acid digestibility measured in the present invention refers to the ratio of the amino acids in the food that can be absorbed and utilized by the digestive tract of the organism (including amino acids contained in proteins and peptides and free amino acids). It can be considered that the protein / amino acid digestibility measured in the present invention essentially refers to the bioavailability of protein / amino acids.

[0084] Experimental results:

[0085] 1) Weight changes of piglets in each group

[0086] From the time the piglets were enrolled (D1) to the 15th day (D15), the weight of the piglets was recorded at a fixed time every 3 days to track the changes in their weight.

[0087] The results are as follows Figure 1There was no significant difference in the weight changes of piglets in each group, and no adverse phenomena such as loss of appetite, flatulence or diarrhea were observed in the piglets during the 15-day feeding period, indicating that the test formula can meet the normal growth needs of piglets.

[0088] 2) Determination of amino acid composition of each group of formula

[0089] Before feeding the piglets, the composition of tyrosine, phenylalanine and tryptophan in each group of formulas was measured to clarify the amino acid composition of different formulas before digestion.

[0090] The contents of tyrosine, phenylalanine and tryptophan in each group Figure 2 There was no significant difference in the total amino acid content among groups 1-4.

[0091] 3) Protein digestibility of each group

[0092] After the piglets were fed with each formula for 15 days, ileal digesta samples were collected, freeze-dried, ground, and the protein in the digesta samples of each group was determined to calculate the apparent digestibility of protein in each group.

[0093] Figure 3 is the apparent digestibility of protein in each group. The results showed that the protein digestibility of each group was about 80%, and there was no statistical difference.

[0094] 4) Apparent digestibility of amino acids in each group

[0095] After the piglets were fed with each formula for 15 days, ileal digesta samples were collected, freeze-dried, and ground. The aromatic amino acids in the digesta samples of each group were determined, and the apparent digestibility of aromatic amino acids in each group was calculated.

[0096] The apparent digestibility of each amino acid is shown in Figure 4 As shown. The apparent digestibility of tyrosine and tryptophan in each group was significantly different, among which the apparent digestibility of tyrosine and tryptophan in group 4 was the highest, followed by groups 1 and 3. Because group 2 did not add taurine and choline, its digestibility of tyrosine and tryptophan was lower than that of the other groups, especially the apparent digestibility of tryptophan was significantly lower than that of the other three groups.

[0097] Figure 5 The apparent digestibility of aromatic amino acids (combined) is consistent with the apparent digestibility of tyrosine, phenylalanine and tryptophan. The apparent digestibility of aromatic amino acids in group 4 is the highest, followed by groups 1 and 3. Since group 2 does not have taurine and choline added, the digestibility of aromatic amino acids is lower than that of other groups.

[0098] 5) Standard digestibility of each amino acid group

[0099] After calculating the apparent digestibility of aromatic amino acids in each group, the standard digestibility of aromatic amino acids in different groups was calculated based on the basic endogenous loss of amino acids measured in the nitrogen-free diet group.

[0100] The standard digestibility of each amino acid is as follows Figure 6 As shown in the figure, similar to the apparent digestibility trend, the standardized digestibility of the aromatic amino acids tyrosine and tryptophan in Group 4 and Group 1 was higher than that in Group 3 and Group 2. Although there was no statistical difference in the standardized digestibility of phenylalanine among the groups, after analyzing Group 2 and Group 4, a trend of statistical difference was found between the two groups (p=0.088).

[0101] Figure 7 The standard digestibility of aromatic amino acids (combined) is consistent with the apparent digestibility trend of tyrosine, phenylalanine and tryptophan. The apparent digestibility of aromatic amino acids in Group 4 and Group 1 is the highest, followed by Group 3. Because Group 2 does not have taurine and choline added, the digestibility of aromatic amino acids is lower than that of other groups.

[0102] The above experiments can show that the present invention can effectively improve the bioavailability of aromatic amino acids in food by controlling the content ratio of taurine and choline in infant formula, and can especially promote the absorption and utilization of tryptophan and / or tyrosine. Therefore, the composition comprising protein, taurine and choline provided by the present invention can be applied to infant formula, can improve protein quality, and improve the bioavailability of aromatic amino acids, so that the demand of infants for amino acids can be met while appropriately reducing the protein concentration in infant formula (to reduce the intake of limiting amino acids), and avoid excessive amino acid intake from burdening the immature kidneys and livers of infants.

[0103] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.

Claims

1. Use of a composition in the preparation of a product for improving the bioavailability of aromatic amino acids, characterized in that: The composition comprises: protein, taurine and choline, wherein the mass ratio of protein, taurine and choline is 1: (0.0019-0.009): (0.008-0.02); the improvement of the bioavailability of aromatic amino acids comprises improving the digestibility and / or absorption utilization rate of one or more of tyrosine and tryptophan.

2. The use according to claim 1, characterized in that: In the composition, the mass ratio of protein, taurine and choline is 1: (0.0020-0.009): (0.0085-0.02).

3. The use according to claim 1, characterized in that: In the composition, the mass ratio of protein, taurine and choline is 1:(0.0022-0.009):(0.0085-0.018).

4. The use according to claim 1, characterized in that: In the composition, the mass ratio of protein, taurine and choline is 1:(0.0024-0.0085):(0.0085-0.016).

5. The use according to claim 1, characterized in that: In the composition, the mass ratio of protein, taurine and choline is 1: (0.0025-0.0085): (0.010-0.015).

6. The use according to claim 1, characterized in that: The protein is plant protein and / or animal protein.

7. The use according to claim 1, characterized in that: The protein is selected from cow milk protein and / or goat milk protein.

8. The use according to claim 1 or 7, characterized in that: The whey protein content in the protein is not less than 40%.

9. The use according to claim 1, characterized in that: The product is a nutritional product.

10. The use according to claim 1, characterized in that: The product is a food.

11. The use according to claim 10, characterized in that: The added amount of the composition in food is 6g-36g / 100g of food dry matter, calculated by protein.

12. The use according to claim 10, characterized in that: The food is milk powder or liquid milk.

13. The use according to claim 10, characterized in that: The food is infant formula, toddler formula or special medical purpose infant formula.